Format

Send to

Choose Destination
See comment in PubMed Commons below
Am J Hum Genet. 2003 May;72(5):1308-14. Epub 2003 Apr 10.

The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype.

Author information

1
Department of Clinical Genetics, Erasmus MC, Rotterdam, The Netherlands.

Abstract

Because of genetic heterogeneity, the identification of breast cancer-susceptibility genes has proven to be exceedingly difficult. Here, we define a new subset of families with breast cancer characterized by the presence of colorectal cancer cases. The 1100delC variant of the cell cycle checkpoint kinase CHEK2 gene was present in 18% of 55 families with hereditary breast and colorectal cancer (HBCC) as compared with 4% of 380 families with non-HBCC (P<.001), thus providing genetic evidence for the HBCC phenotype. The CHEK2 1100delC mutation was, however, not the major predisposing factor for the HBCC phenotype but appeared to act in synergy with another, as-yet-unknown susceptibility gene(s). The unequivocal definition of the HBCC phenotype opens new avenues to search for this putative HBCC-susceptibility gene.

PMID:
12690581
PMCID:
PMC1180284
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center